SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

GSK backtracks on Memphis divestment plans, invests $2m

25-Aug-2015 - A GSK facility in Memphis Tennessee which was scheduled to be sold off will now receive $2m to improve its manufacturing infrastructure.

‘Eat or be eaten;’ Mylan says Perrigo could be run as subsidiary

25-Aug-2015 - Mylan will run Perrigo as a wholly-owned subsidiary if it acquires between 50-80% of shares, the firm has clarified.

News in brief

CMO Regis Technologies opens potent API site

25-Aug-2015 - Regis Technologies has opened a site for manufacturing highly potent active pharmaceutical ingredients (HPAPIs) in Illinois.

News in brief

Merck recalls 276,000 pill bottles

20-Aug-2015 - Merck & Co. has recalled two chemotherapy products because of cracked caps, including one it manufactures for Novartis’ Sandoz.

Italy bans 7 APIs from compounding pharmacies after off-label abuse

20-Aug-2015 - The Italian Ministry of Health has banned compounding pharmacies from preparing drugs containing any of seven APIs after chemists were discovered making dangerous off-label weight loss treatments.

Pharma plants strike in Pakistan to protest QC rule changes

19-Aug-2015 - Pakistani pharmaceutical manufacturers are today halting production in protest at changes to manufacturing regulations.

Lundbeck cuts 1,000 jobs

19-Aug-2015 - Danish drugmaker Lundbeck has announced plans to slash 1,000 jobs as part of a massive restructuring.

Tianjin explosions hit GSK pharma production site

18-Aug-2015 - Explosions last week at a warehouse in Tianjin, China hit a GSK drug manufacturing plant, in-Pharmatechnologist.com can reveal.

Merck & Co. plans over 2,500 manufacturing job cuts

17-Aug-2015 - An SEC filing reveals Merck has cut 29,160 jobs in five years, and over 2,500 more may be on the way.

Still no plans to resume manufacturing at former Ben Venue plant

17-Aug-2015 - The huge former Ben Venue injectables manufacturing plant in Ohio that became the center of controversy over drug shortages a few years ago remains off line, and the company that now owns the site reiterated this week that it has no plans to resume making products there.

PEOPLE ON THE MOVE

Job-hunting? GSK looking for 140 staff at NC plant

06-Aug-2015 -

Success of Allergan integration is the human capital, says Teva

03-Aug-2015 - "People are the essence of the company going forward," said Teva, referring to the news that the world's largest generic drug maker will purchase Allergan's generics business for $40.5bn, at its Q2 financial results press conference on Thursday.

US FDA finalises analytical procedures and methods validation guidance

28-Jul-2015 - Pharma firms may need to carry-out an analytical method comparability study as part of the life cycle management of a drug, according to final US FDA guidelines.

Update

Teva to buy Allergan's generics biz for $40.5bn

27-Jul-2015 - Teva has struck a deal to buy Allergan’s generics business a week after its persistent attempts to acquire Mylan fell through.

Sandoz shutters German and Indian production sites

23-Jul-2015 - Sandoz has revealed it will close three manufacturing sites in Germany and India.

J&J plans to reopen site in PA, relaunch OTC portfolio

21-Jul-2015 - J&J says it expects to reopen the Pennsylvania site it was forced to close after a spate of manufacturing problems with its OTC pain drugs.

Summit up as Celgene steps in to buy Merck & Co. campus

21-Jul-2015 - Celgene will take over a Merck & Co. facility in Summit, New Jersey which had been earmarked for closure.

News in brief

Torrent acquires Indian dermatological drugmaker Zyg

20-Jul-2015 - Torrent Pharma has added two facilities to its network through the acqusition of Zyg Pharma from the Encore Group.

News in brief

Pfizer to close Mumbai manufacturing facility

16-Jul-2015 - With no active production at the plant since 2013, the company said it would shutter its Mumbai, India-based facility in mid-September, according to a Bombay Stock Exchange filing . 

Fresenius Kabi fined £500,000 after patient death

13-Jul-2015 - Fresenius Kabi and a UK drug manufacturer have been sentenced for supplying faulty insulin syringes which contributed to a diabetic man’s death.

Hovione upping spray drying capacity to support rise in low solubility drugs

08-Jul-2015 - A new unit will up Hovione’s spray drying capacity 20% as it predicts a surge in demand for such a service in overcoming drug solubility issues.

Allergan targets Actavis legacy plant in Iceland in cost-cutting move

02-Jul-2015 - Manufacturing operations at an Actavis legacy site in Iceland will cease and products will be transferred out the country from 2016, Allergan has announced.

Hospira's Vizag plant begins sterile production following US FDA approval

02-Jul-2015 - Hospira has begun commercial production at a sterile injectable plant in India hit with several 483 forms after the US FDA deemed the site ‘acceptable.’

GSK investing $60m in greener manufacturing at Singapore amoxicillin plant

01-Jul-2015 - GSK is investing £38m ($60m) in enzymatic manufacturing at an antibiotic facility in Singapore which the firm says is greener and more efficient than traditional approaches.

'Outperform' Perrigo better off without Mylan, says analyst report

30-Jun-2015 - The proposed Perrigo merger with Mylan would be of no benefit to either firm in the “highly competitive” OTC sector, according to financial analysts BMO.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...